Clinical trials: Rabies Human

Rabies Human, Antibody Titer

Vaccine Prevention of Rabies Adopts 4-shot Immunization Method

• Completed
• Age: 10 to 60 years
• Phase 3
• Vaccines

A phase III clinical trial to evaluate the immunogenicity and safety of freeze-dried human rabies vaccine (Vero cell) developed by Changchun Zhuoyi Biological Co., Ltd. inoculated in a 4-dose procedure (2-1-1)

Trial name

NCT05549908

Testing

rabies vaccine

Where

China

Volunteers

1,800 people, healthy volunteers welcome

Sponsor

Changchun Zhuoyi Biological Co., Ltd